Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GABAPENTIN ENACARBIL vs GADODIAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GABAPENTIN ENACARBIL vs GADODIAMIDE: Safety Overview

Metric GABAPENTIN ENACARBIL GADODIAMIDE
Total FAERS Reports 1,833 777
Deaths Reported 649 37
Death Rate 35.4% 4.8%
Hospitalizations 237 67
Average Patient Age 54.6 yrs 49.7 yrs
% Female Patients 61.5% 64.6%
FDA Approval Date Apr 6, 2011 Jan 8, 1993
Manufacturer Azurity Pharmaceuticals, Inc. (former... GE Healthcare Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription